180 related articles for article (PubMed ID: 27183549)
1. Choroidal Neovascularization Associated With Birdshot Chorioretinopathy.
Shantha JG; Ho VY; Patel P; Forooghian F; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):450-7. PubMed ID: 27183549
[TBL] [Abstract][Full Text] [Related]
2. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
3. Recurrence Rate of Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol.
Adrean SD; Chaili S; Grant S; Pirouz A
Ophthalmol Retina; 2018 Mar; 2(3):225-230. PubMed ID: 31047590
[TBL] [Abstract][Full Text] [Related]
4. Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.
Rishi P; Rishi E; Bhende M; Agarwal V; Vyas CH; Valiveti M; Bhende P; Rao C; Susvar P; Sen P; Raman R; Khetan V; Murali V; Ratra D; Sharma T
Br J Ophthalmol; 2016 Oct; 100(10):1337-40. PubMed ID: 26792945
[TBL] [Abstract][Full Text] [Related]
5. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
Steinle NC; Du W; Gibson A; Saroj N
Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
[TBL] [Abstract][Full Text] [Related]
6. Etiology, Treatment Patterns, and Outcomes for Choroidal Neovascularization in the Pediatric Population: An Intelligent Research in Sight (IRIS®) Registry Study.
Finn AP; Fujino D; Lum F; Rao P
Ophthalmol Retina; 2022 Feb; 6(2):130-138. PubMed ID: 34091079
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
[TBL] [Abstract][Full Text] [Related]
8. HOW VITREOMACULAR INTERFACE MODIFIES THE EFFICACY OF ANTI-VEGF THERAPY FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Iuliano L; Bandello F
Retina; 2018 Jan; 38(1):84-90. PubMed ID: 28098725
[TBL] [Abstract][Full Text] [Related]
9. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
[TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.
Battaglia Parodi M; Romano F; Marchese A; Arrigo A; Llorenç V; Cicinelli MV; Bandello F; Adán A
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):273-278. PubMed ID: 30470876
[TBL] [Abstract][Full Text] [Related]
11. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS
Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.
Tran TH; Fardeau C; Terrada C; Ducos De Lahitte G; Bodaghi B; Lehoang P
Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1685-92. PubMed ID: 18682970
[TBL] [Abstract][Full Text] [Related]
13. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
[TBL] [Abstract][Full Text] [Related]
14. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
Chhablani J; Pichi F; Silva R; Casella AM; Murthy H; Banker A; Nowilaty SR; Carrai P; Nucci P; Arevalo JF;
Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor.
Roy R; Saurabh K; Bansal A; Kumar A; Majumdar AK; Paul SS
Indian J Ophthalmol; 2017 Apr; 65(4):295-300. PubMed ID: 28513493
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.
Barth T; Zeman F; Helbig H; Gamulescu MA
Int Ophthalmol; 2018 Jun; 38(3):923-931. PubMed ID: 28424992
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy.
Steeples LR; Spry P; Lee RWJ; Carreño E
Int Ophthalmol; 2018 Jun; 38(3):1357-1362. PubMed ID: 28608031
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Administration of Ranibizumab and Bevacizumab for Choroidal Neovascularization Secondary to Ocular Toxocariasis: A Case Report.
Yoon DY; Woo SJ
Ocul Immunol Inflamm; 2018; 26(4):639-641. PubMed ID: 27775459
[TBL] [Abstract][Full Text] [Related]
19. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctate inner choroidopathy.
Cornish KS; Williams GJ; Gavin MP; Imrie FR
Eur J Ophthalmol; 2011; 21(4):440-5. PubMed ID: 21188681
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
Gabrielle PH; Nguyen V; Creuzot-Garcher C; Miguel L; Alforja S; Sararols L; Casaroli-Marano RP; Zarranz-Ventura J; Gillies M; Arnold J; Barthelmes D
Acta Ophthalmol; 2022 Feb; 100(1):e288-e296. PubMed ID: 33960115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
